Source: Virtual Congress 2020 – Possible scenarios in the challenging future of rare diffuse parenchymal lung diseases
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Planas Cerezales (Hospitalet de Llobregat (Barcelona), Spain), E. Arias-Salgado (Madrid, Spain), C. Berastegui Garcia (Barcelona, Spain), A. Montes Worboys (Hospitalet de Llobregat, Spain), R. Gonzalez Montelongo (Santa Cruz de Tenerife, Spain), J. Lorenzo Salazar (Santa Cruz de Tenerife, Spain), V. Vicens-Zygmunt (Hospitalet de Llobregat, Spain), M. Garcia Moyano (Baracaldo, Spain), J. Dorca (Hospitalet de Llobregat, Spain), C. Flores (Santa Cruz de Tenerife, Spain), R. Perona (Madrid, Spain), A. Román (Barcelona , Spain), M. Molina-Molina (Hospitalet de Llobregat, Spain). Increase in post-transplant survival and quality of life in pulmonary fibrosis with and without telomere dysfunction. 5255

Member's Comments

No comment yet.

Related content which might interest you: Assessing quality of life of idiopathic pulmonary fibrosis patients: the INSTAGE study Source: Breathe, 15 (2) 144; 10.1183/20734735.0016-2019 Year: 2019 Effect of low dose pirfenidone on survival and lung function decline in patients with idiopathic pulmonary fibrosis (IPF): results from a real life study Source: Virtual Congress 2021 – News in treatment and diagnosis of idiopathic interstitial pneumonia Year: 2021 Inflammation and infection in infants with cystic fibrosis is associated with changes in lung function in the first year of life Source: Annual Congress 2008 - Respiratory physiology in health and disease Year: 2008 Pulmonary function, inflammation, exercise capacity and quality of life in cystic fibrosis Source: Eur Respir J 2001; 17: 712-715 Year: 2001 Predictors of quality of life in patients with interstitial lung disease Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease Year: 2009 Health-related quality of life and disease progression in pulmonary arterial hypertension patients: a 3-year study Source: ERJ Open Res, 7 (3) 00617-2020; 10.1183/23120541.00617-2020 Year: 2021 Is there a relationship between quality of life and exercise performance in idiopathic pulmonary fibrosis (IPF)? Source: Eur Respir J 2007; 30: Suppl. 51, 577s Year: 2007 Post-transplant morbidity and mortality in patients with pulmonary fibrosis and telomeric shortening Source: International Congress 2017 – The wide spectrum of ILDs Year: 2017 Health-related quality of life in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 Measurement of quality of life in pulmonary hypertension and its significance Source: Eur Respir J 2006 Oct 01;28(4):808-815 Year: 2006 Relationship between quality of life and pulmonary function Source: Eur Respir J 2001; 18: Suppl. 33, 44s Year: 2001 Impaired pulmonary function and its association with clinical outcomes, exercise capacity and quality of life in children with congenital heart disease Source: Virtual Congress 2020 – Clinical year in review Year: 2020 Health-related quality of life and health status among patients with sarcoidosis, chronic obstructive pulmonary disease and interstitial lung disease Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management Year: 2018 The impact of energetic reserve on pulmonary function, quality of life and dyspnoea in patients with chronic obstructive pulmonary disease Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007 Shorter telomere length following lung transplantation is associated with clinically significant leukopenia and decreased chronic lung allograft dysfunction-free survival Source: ERJ Open Res, 6 (2) 00003-2020; 10.1183/23120541.00003-2020 Year: 2020 The effect of pulmonary rehabilitation on health-related quality of life in patients with pulmonary sarcoidosis Source: International Congress 2018 – Telehealth, home rehabilitation and specific adaptations to exercise interventions in different settings Year: 2018 The association between leukocyte telomere length, telomere attrition and disease severity in cystic fibrosis patients Source: International Congress 2017 – Cystic fibrosis: monitoring and biomarkers Year: 2017 Role of skeletal muscle dysfunction in the deterioration  of life quality in patients with COPD Source: International Congress 2017 – Extrapulmonary comorbidities in COPD Year: 2017 Patients’ expectations and quality of life before introduction of pirfenidone used in idiopathic pulmonary fibrosis. Source: International Congress 2018 – Management of idiopathic interstitial pneumonias: established and new treatments Year: 2018 The effect of pulmonary rehabilitation on exercise tolerance pulmonary function dyspnea and quality of life in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation Year: 2013